Tuon Felipe Francisco, Gasparetto Juliano, Wollmann Luciana Cristina, Moraes Thyago Proença de
Pontifícia Universidade Católica do Paraná, Escola de Saúde e Biociências, Departamento de Medicina, Curitiba, PR, Brazil.
Pontifícia Universidade Católica do Paraná, Escola de Saúde e Biociências, Departamento de Medicina, Curitiba, PR, Brazil.
Braz J Infect Dis. 2017 Nov-Dec;21(6):660-664. doi: 10.1016/j.bjid.2017.08.002. Epub 2017 Sep 21.
Technologies applied to mobile devices can be an important strategy in antibiotic stewardship programs.
The aim of this study was to determine the impact of a decision-making application on antibiotic prescription.
This was an observational, analytical and longitudinal study on the implementation of an antimicrobial guide for mobile application. This study analyzed the period of 12 months before and 12 months after the app implementation at a university hospital based on local epidemiology, avoiding high cost drugs and reducing the potential for drug resistance including carbapenem. Antimicrobials consumption was evaluated in Daily Defined Dose/1000 patients-day and direct expenses converted into USD.
The monthly average consumption of aminoglycosides and cefepime had a statistically significant increase (p<0.05), while the consumption of piperacillin/tazobactam and meropenem was significantly decreased (p<0.05). The sensitivity to meropenem as well as to polymyxin increased after the app implementation. A decrease in sensitivity to cefepime was observed after introduction of this antibiotic as a substitute of piperacillin/tazobactam for treating intra-hospital infections. There was a net saving of USD 296,485.90 (p<0.05).
An antibiotic protocol in the app can help antibiotic stewardship reducing cost, changing the microbiological profile and antimicrobial consumption.
应用于移动设备的技术可以成为抗生素管理计划中的一项重要策略。
本研究旨在确定决策应用程序对抗生素处方的影响。
这是一项关于移动应用抗菌指南实施情况的观察性、分析性和纵向研究。本研究分析了大学医院应用程序实施前12个月和实施后12个月的时间段,依据当地流行病学情况,避免使用高成本药物,并降低包括碳青霉烯类在内的耐药可能性。抗菌药物消耗量以每日限定剂量/1000患者日为单位进行评估,直接费用换算为美元。
氨基糖苷类和头孢吡肟的月平均消耗量有统计学显著增加(p<0.05),而哌拉西林/他唑巴坦和美罗培南的消耗量显著下降(p<0.05)。应用程序实施后,对美罗培南以及多粘菌素的敏感性增加。在引入头孢吡肟作为哌拉西林/他唑巴坦治疗医院内感染的替代药物后,观察到对头孢吡肟的敏感性下降。净节省296,485.90美元(p<0.05)。
应用程序中的抗生素方案有助于抗生素管理,降低成本,改变微生物学特征和抗菌药物消耗量。